Phase I Study Of SU011248 In Combination With Pemetrexed, Pemetrexed/Cisplatin And Pemetrexed/Carboplatin In Patients With Advanced Solid Malignancies.
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2011
At a glance
- Drugs Carboplatin; Cisplatin; Pemetrexed; Sunitinib
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Pfizer
- 19 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Apr 2010 Actual patient number (96) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.